Bacillus Calmette-Guérin (BCG) shortages and the fragile BCG supply chain have created a bladder cancer treatment vacuum.

SARS-CoV-2 mRNA vaccination within 100 days of ICI initiation was associated with increased overall survival in patients with NSCLC or metastatic melanoma.

(HealthDay News) — Cannabis use in 2017 was associated with regular tobacco use in 2021 among U.S. youth and young adults who had never regularly used tobacco, according to a study published online ...

While mycophenolate mofetil is standard of care treatment for lupus nephritis, belimumab might be an alternative.

Associations seen for HIV infection, SARS-CoV-2 infection, other viral infections with coronary heart disease, stroke.

The Food and Drug Administration (FDA) has granted Priority Review to enfortumab vedotin-ejfv (Padcev ™) in combination with pembrolizumab (Keytruda ®) as a neoadjuvant treatment and then continued ...

Patient and graft survival similar for patients receiving DCD-V from MAiD donation versus conventional DCD-III grafts.

The phase 3 ALBAN trial tested atezolizumab plus BCG in BCG-naïve patients with high-risk, non-muscle-invasive bladder cancer (NMIBC).

The FDA has expanded the approval of Winrevair to include treatment of adults with PAH WHO Group 1 to improve exercise capacity and WHO FC, and reduce the risk of clinical worsening events including ...

(HealthDay News) — Primary care physicians (PCPs) spend an average of 61.8 hours per week caring for a patient panel, according to a study published online Oct. 21 in the Annals of Internal Medicine.

The phase 3 POTOMAC trial tested durvalumab added to BCG in patients with high-risk non-muscle-invasive bladder cancer (NMIBC).

PlGF cutoff <100 pg/mL demonstrated 100 percent sensitivity and specificity at 20 to 24 weeks of gestation for early-onset preeclampsia.